These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6740856)

  • 1. Palliative nephrostomy for relief of ureteral obstruction secondary to malignancy.
    Bodner D; Kursh ED; Resnick MI
    Urology; 1984 Jul; 24(1):8-10. PubMed ID: 6740856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pigtail ureteral stent in the cancer patient.
    Hepperlen TW; Mardis HK; Kammandel H
    J Urol; 1979 Jan; 121(1):17-8. PubMed ID: 83394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indications for percutaneous nephrostomy in patients with obstructive uropathy due to malignant urogenital neoplasias.
    Romero FR; Broglio M; Pires SR; Roca RF; Guibu IA; Perez MD
    Int Braz J Urol; 2005; 31(2):117-24. PubMed ID: 15877830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of ureteral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes.
    Kouba E; Wallen EM; Pruthi RS
    J Urol; 2008 Aug; 180(2):444-50. PubMed ID: 18550089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous nephrostomy for ureteral obstruction in patients with gynecologic malignancy.
    Coddington CC; Thomas JR; Hoskins WJ
    Gynecol Oncol; 1984 Jul; 18(3):339-48. PubMed ID: 6204911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrostomy in cancer patients: to do or not to do?
    Fallon B; Olney L; Culp DA
    Br J Urol; 1980 Aug; 52(4):237-42. PubMed ID: 7426987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrostomy in patients with ureteral obstruction secondary to nonurologic malignancy. Obstructive uropathy in malignant disease.
    McNamara TE; Butkus DE
    Arch Intern Med; 1980 Apr; 140(4):494-7. PubMed ID: 7362379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessment of circle tube nephrostomy in advanced pelvic malignancy.
    Kohler JP; Lyon ES; Schoenberg HW
    J Urol; 1980 Jan; 123(1):17-8. PubMed ID: 7351714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous nephrostomy for ureteric obstruction due to advanced pelvic malignancy: have we got the balance right?
    Misra S; Coker C; Richenberg J
    Int Urol Nephrol; 2013 Jun; 45(3):627-32. PubMed ID: 23666587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous nephrostomy for palliation of metastatic ureteral obstruction.
    Culkin DJ; Wheeler JS; Marsans RE; Nam SI; Canning JR
    Urology; 1987 Sep; 30(3):229-31. PubMed ID: 2442872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prompt management of anastomotic leak or acute obstruction after minimally invasive pyeloplasty with percutaneous nephrostomy preserves outcomes.
    Ozayar A; Morgan MS; Friedlander JI; Saumur M; Krishan G; Gahan JC; Cadeddu JA
    J Urol; 2014 Dec; 192(6):1716-9. PubMed ID: 24952241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection for percutaneous nephrostomy in gynecologic cancer patients.
    Feuer GA; Fruchter R; Seruri E; Maiman M; Remy JC; Boyce JG
    Gynecol Oncol; 1991 Jul; 42(1):60-3. PubMed ID: 1916512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pyelonephrostomy as a life-extending measure in terminal cancer].
    Kratzik C; Kuber W
    Z Urol Nephrol; 1982 Mar; 75(3):159-65. PubMed ID: 7102127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous nephrostomy and antegrade ureteral stent insertion.
    Elyaderani MK; Gabriele OF; Kandzari SJ; Belis JA
    Urology; 1982 Dec; 20(6):650-6. PubMed ID: 7179639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous nephrostomy in gynecologic oncology patients.
    Soper JT; Blaszczyk TM; Oke E; Clarke-Pearson D; Creasman WT
    Am J Obstet Gynecol; 1988 May; 158(5):1126-31. PubMed ID: 2453117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of percutaneous nephrostomy in malignant ureteric obstruction.
    Wilson JR; Urwin GH; Stower MJ
    Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
    Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
    J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of percutaneous nephrostomy in malignant urinary tract obstruction.
    Watkinson AF; A'Hern RP; Jones A; King DM; Moskovic EC
    Clin Radiol; 1993 Jan; 47(1):32-5. PubMed ID: 8428414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relief of upper urinary tract obstruction in patients with cancer of the prostate].
    Kraemer PC; Borre M
    Ugeskr Laeger; 2009 Mar; 171(11):873-6. PubMed ID: 19278608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous nephrostomy versus indwelling ureteral stents in patients with bilateral nongenitourinary malignant extrinsic obstruction.
    Park DS; Park JH; Lee YT
    J Endourol; 2002 Apr; 16(3):153-4. PubMed ID: 12028623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.